Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum

Genitourinary Medicine

Volumn 72, Issue 2, 1996, Pages 111-114

  Monsonego, J ^a   Cessot, G ^a   Ince, S E ^b   Galazka, A R ^b   Abdul Ahad, A K ^b  

^a INSTITUT ALFRED FOURNIER   (France)

^b Serono International SA   (Switzerland)

Author keywords

Condyloma acuminatum; Interferon; Papilloma virus

Indexed keywords

PLACEBO; RECOMBINANT BETA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFLUENZA; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029877215     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.72.2.111     Document Type: Article

References (23)

1. Nuovo GJ, Blanco JS, Leipzig S, Smith D. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia. Obstet Gyncol 1990;75:1006-11.
2. Phelps WC, Alexander KA. Antiviral therapy for human papillomaviruses: Rationale and prospects. Ann Intern Med 1995;123:368-82.
3. Ferenczy A. Epidemiology and clinical pathophysiology of condylomata acuminata. Am J Obstet Gynecol 1995;172:1331-39.
4. Bosch FX, Maños MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Nat Canc Inst 1995;87:796-802.
5. Ferenczy A, Mitao M, Nagau N, et al. Latent papillomavirus and recurring genital warts. N Engl J Med 1985;313:784-8.
6. Scott GM, Csonka GW. Effect of injections of small doses of human fibroblast interferon into genital warts: a pilot study. Br J Venereal Dis 1979;55:442-5.
7. Geffen JR, Klein RJ, Friedman-Klein AE. Intralesional administration of large doses of human leukocyte interferon for the treatment of condylomata acuminata. J Infect Dis 1984;150:612-5.
8. Eron LJ, Judson F, Tucker S, et al. Interferon therapy for condylomata acuminata. N Engl J Med 1986;315:1059-64.
9. Vance JC, Bart BJ, Hansen RC, et al. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 1986;122:272-7.
10. Friedman-Kien AE, Eron LJ, Conant M, et al. Natural interferon alfa for treatment of condylomata acuminata. JAMA 1988;259:533-8.
11. Kirby P. Interferon in genital warts: much potential, modest progress. JAMA 1988;259:570-2.
12. Reichman RC, Oakes D, Bonnez W, et al. Treatment of condylomata acuminatum with three different interferons administered intralesionally. Ann Intern Med 1988;108:675-9.
13. Conover WJ. Some methods based on ranks. In: Practical Nonparametric Statistics (2nd ed.). New York: Wiley J and Sons, 1980:294-99.
14. Schonfeld A, Nitke S, Schattner A, et al. Intramuscular human interferon-b injections in treatment of condyloma acuminata. Lancet 1984;I:1038-41.
15. Olmos L, Vilata J, Rodriguez Pichardo A, et al. Double-blind randomised clinical trial on the effect of interferon-beta in the treatment of condylomata acuminata. Int J STD AIDS 1994;5:182-5.
16. Costa S, Poggi MG, Palmisano L, et al. Intramuscular bi-nterferon treatment of human papillomavirus lesions in the lower female genital tract. Cervix & Lower Female Genital Tract 1984;6:203-12.
17. Welander Charles E, Homesley HD, Smiles KA, et al. Intralesional interferon alpha-2b for the treatment of genital warts. Am J Gynecol 1990;162:848-54.
18. Turek LP, Byrne JC, Lowy DR, et al. Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus transformed mouse cells. Proc Natl Acad Sci USA 1982;79:7914-8.
19. Gangemi JD, Pirisi L, Angell M, et al. HPV replication in experimental models: effects on interferon. Antiviral Res 1994;24:175-90.
20. Aray I, Rady P, Tying SK. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papillomavirus infected cells through the inhibitory TGF-beta-1/IFN-beta cytokine pathway. Antiviral Res 1994;23:131-41.
21. Douglas JM, Rogers M, Judson FN. The effect of asymptomatic infection with HTLV-III on the response of genital warts to intralesional treatment with recombinant alpha 2 interferon. J Infect Dis 154:331-4.
22. Handley J, Dinsmore W. Treatment of anogenital warts. J Eur Acad Dermatol Venereol 1994;3:251-65.
23. Hatch KD. Clinical appearance and treatment strategies for human papillomavirus: a gynecologic perspective. Am J Obstet Gynecol 1995;172:1340-4.